Literature DB >> 21123951

Adult combined GH, prolactin, and TSH deficiency associated with circulating PIT-1 antibody in humans.

Masaaki Yamamoto1, Genzo Iguchi, Ryoko Takeno, Yasuhiko Okimura, Toshiaki Sano, Michiko Takahashi, Hitoshi Nishizawa, Anastasia Evi Handayaningshi, Hidenori Fukuoka, Maya Tobita, Takatoshi Saitoh, Katsuyoshi Tojo, Atsuko Mokubo, Akio Morinobu, Keiji Iida, Hidesuke Kaji, Susumu Seino, Kazuo Chihara, Yutaka Takahashi.   

Abstract

The pituitary-specific transcriptional factor-1 (PIT-1, also known as POU1F1), is an essential factor for multiple hormone-secreting cell types. A genetic defect in the PIT-1 gene results in congenital growth hormone (GH), prolactin (PRL), and thyroid-stimulating hormone (TSH) deficiency. Here, we investigated 3 cases of adult-onset combined GH, PRL, and TSH deficiencies and found that the endocrinological phenotype in each was linked to autoimmunity directed against the PIT-1 protein. We detected anti-PIT-1 antibody along with various autoantibodies in the patients' sera. An ELISA-based screening revealed that this antibody was highly specific to the disease and absent in control subjects. Immunohistochemical analysis revealed that PIT-1-, GH-, PRL-, and TSH-positive cells were absent in the pituitary of patient 2, who also had a range of autoimmune endocrinopathies. These clinical manifestations were compatible with the definition of autoimmune polyendocrine syndrome (APS). However, the main manifestations of APS-I--hypoparathyroidism and Candida infection--were not observed and the pituitary abnormalities were obviously different from the hypophysitis associated with APS. These data suggest that these patients define a unique "anti-PIT-1 antibody syndrome," related to APS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21123951      PMCID: PMC3007153          DOI: 10.1172/JCI44073

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Biologically inactive growth hormone caused by an amino acid substitution.

Authors:  Y Takahashi; H Shirono; O Arisaka; K Takahashi; T Yagi; J Koga; H Kaji; Y Okimura; H Abe; T Tanaka; K Chihara
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 2.  Pit-1: clinical aspects.

Authors:  R Pfäffle; C Kim; B Otten; J M Wit; U Eiholzer; G Heimann; J Parks
Journal:  Horm Res       Date:  1996

Review 3.  Role of Pit-1 in the gene expression of growth hormone, prolactin, and thyrotropin.

Authors:  L E Cohen; F E Wondisford; S Radovick
Journal:  Endocrinol Metab Clin North Am       Date:  1996-09       Impact factor: 4.741

4.  A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype.

Authors:  H A Ingraham; R P Chen; H J Mangalam; H P Elsholtz; S E Flynn; C R Lin; D M Simmons; L Swanson; M G Rosenfeld
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

5.  An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains.

Authors: 
Journal:  Nat Genet       Date:  1997-12       Impact factor: 38.330

6.  Positional cloning of the APECED gene.

Authors:  K Nagamine; P Peterson; H S Scott; J Kudoh; S Minoshima; M Heino; K J Krohn; M D Lalioti; P E Mullis; S E Antonarakis; K Kawasaki; S Asakawa; F Ito; N Shimizu
Journal:  Nat Genet       Date:  1997-12       Impact factor: 38.330

7.  Pit-1 binding sites mediate transcriptional responses to cyclic adenosine 3',5'-monophosphate through a mechanism that does not require inducible phosphorylation of Pit-1.

Authors:  Y Okimura; P W Howard; R A Maurer
Journal:  Mol Endocrinol       Date:  1994-11

8.  Association of HLA-A24 with complete beta-cell destruction in IDDM.

Authors:  K Nakanishi; T Kobayashi; T Murase; T Nakatsuji; H Inoko; K Tsuji; K Kosaka
Journal:  Diabetes       Date:  1993-07       Impact factor: 9.461

9.  Immunogenetic and clinical characterization of slowly progressive IDDM.

Authors:  T Kobayashi; K Tamemoto; K Nakanishi; N Kato; M Okubo; H Kajio; T Sugimoto; T Murase; K Kosaka
Journal:  Diabetes Care       Date:  1993-05       Impact factor: 19.112

10.  Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1.

Authors:  S Li; E B Crenshaw; E J Rawson; D M Simmons; L W Swanson; M G Rosenfeld
Journal:  Nature       Date:  1990-10-11       Impact factor: 49.962

View more
  19 in total

1.  Autoimmunity: acquired versus inherited pituitary deficiency - same difference?

Authors:  Jacques Drouin; Shinobu Takayasu
Journal:  Nat Rev Endocrinol       Date:  2011-05       Impact factor: 43.330

Review 2.  Idiopathic adult growth hormone deficiency.

Authors:  Shlomo Melmed
Journal:  J Clin Endocrinol Metab       Date:  2013-03-28       Impact factor: 5.958

3.  Anti-pituitary antibodies against corticotrophs in IgG4-related hypophysitis.

Authors:  Naoko Iwata; Shintaro Iwama; Yoshihisa Sugimura; Yoshinori Yasuda; Kohtaro Nakashima; Seiji Takeuchi; Daisuke Hagiwara; Yoshihiro Ito; Hidetaka Suga; Motomitsu Goto; Ryoichi Banno; Patrizio Caturegli; Teruhiko Koike; Yoshiharu Oshida; Hiroshi Arima
Journal:  Pituitary       Date:  2017-06       Impact factor: 4.107

4.  Growth hormone and proopiomelanocortin are targeted by autoantibodies in a patient with biopsy-proven IgG4-related hypophysitis.

Authors:  M A Landek-Salgado; P Leporati; I Lupi; A Geis; P Caturegli
Journal:  Pituitary       Date:  2012-09       Impact factor: 4.107

Review 5.  Central hypothyroidism - a neglected thyroid disorder.

Authors:  Paolo Beck-Peccoz; Giulia Rodari; Claudia Giavoli; Andrea Lania
Journal:  Nat Rev Endocrinol       Date:  2017-05-26       Impact factor: 43.330

Review 6.  Growth hormone and adipose tissue: beyond the adipocyte.

Authors:  Darlene E Berryman; Edward O List; Lucila Sackmann-Sala; Ellen Lubbers; Rachel Munn; John J Kopchick
Journal:  Growth Horm IGF Res       Date:  2011-04-05       Impact factor: 2.372

7.  Central hypothyroidism in adults: better understanding for better care.

Authors:  Solange Grunenwald; Philippe Caron
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

Review 8.  Human pituitary development and application of iPSCs for pituitary disease.

Authors:  Ryusaku Matsumoto; Yutaka Takahashi
Journal:  Cell Mol Life Sci       Date:  2020-11-18       Impact factor: 9.261

Review 9.  Insights into non-classic and emerging causes of hypopituitarism.

Authors:  Flavia Prodam; Marina Caputo; Chiara Mele; Paolo Marzullo; Gianluca Aimaretti
Journal:  Nat Rev Endocrinol       Date:  2020-11-27       Impact factor: 43.330

Review 10.  Hypophysitis: An update on the novel forms, diagnosis and management of disorders of pituitary inflammation.

Authors:  Sriram Gubbi; Fady Hannah-Shmouni; Joseph G Verbalis; Christian A Koch
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2019-12-12       Impact factor: 4.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.